chronic limb-threatening ischaemia
Surgical Site Infections in Major Lower Limb Amputation: An International Multicentre Audit (SIMBA): Study Protocol
Introduction Background and rationale Surgical site infection (SSI) is a significant potential complication of any surgical procedure, acknowledged by the National Institute of Health and Care Excellence (NICE) as a leading cause of in-hospital morbidity and mortality.1 In vascular surgery, patients undergoing major lower limb amputation (MLLA) may be at an increased risk of developing…
Read MoreOutcome of covered stents for severe aorto-iliac occlusive disease (AIOD) in patients with chronic limb-threatening ischaemia
Introduction The most recent iteration of the Inter-Society Consensus Document for the Management of Peripheral Arterial Disease from 2015 (Trans-Atlantic Inter-Society Consensus; TASC II) has suggested that all types of aorto-iliac occlusive disease (AIOD) may be treated using either an endovascular or open approach, provided the clinical team has sufficient expertise in the given modality,…
Read MoreUse of Shockwave® intravascular lithotripsy in the treatment of calcific peripheral vascular disease of the crural vessels: a protocol for a systematic review
Introduction Peripheral artery disease (PAD) is a systemic atherosclerotic disease with an increasing prevalence currently estimated at over 230 million adults globally.1,2 PAD prevalence in the infrapopliteal/ crural arterial bed is increasing, influenced by the ageing population, as well as the increasing prevalence of diabetes and chronic kidney disease.1–3 Chronic limb-threatening ischaemia (CLTI), the most…
Read MoreThe role of Braden scores in predicting outcomes following revascularisation for chronic limb-threatening ischaemia and their association with frailty
Introduction Peripheral artery disease (PAD) poses a substantial healthcare burden worldwide as the third leading cause of atherosclerotic vascular morbidity.1 Chronic limb-threatening ischaemia (CLTI) induces rest pain and/or tissue loss and encompasses the end stage of PAD, developing in approximately 11% of PAD patients, and is associated with debilitating pain, poor quality of life, one-year…
Read More
